/PRNewswire/ Global techbio company PrecisionLife, pioneers in precision medicine for chronic diseases, will assess the precision medicine potential of a.
A new partnership between PrecisionLife and Sano Genetics will help advance researchers' understanding of the drivers of long COVID, identifying at-risk patients and potential drug targets PrecisionLife